1. Home
  2. SI vs CCCC Comparison

SI vs CCCC Comparison

Compare SI & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shoulder Innovations Inc.

SI

Shoulder Innovations Inc.

HOLD

Current Price

$17.60

Market Cap

435.3M

Sector

Health Care

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.38

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SI
CCCC
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
435.3M
404.7M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
SI
CCCC
Price
$17.60
$3.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$20.80
$12.20
AVG Volume (30 Days)
77.9K
1.8M
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
98.08
16.45
EPS
N/A
N/A
Revenue
$47,317,000.00
$35,947,000.00
Revenue This Year
$39.59
N/A
Revenue Next Year
$31.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
49.63
1.02
52 Week Low
$10.92
$1.69
52 Week High
$24.60
$5.17

Technical Indicators

Market Signals
Indicator
SI
CCCC
Relative Strength Index (RSI) 31.17 38.87
Support Level $12.42 $3.38
Resistance Level $23.08 $3.91
Average True Range (ATR) 0.99 0.16
MACD -0.22 -0.03
Stochastic Oscillator 10.30 16.97

Price Performance

Historical Comparison
SI
CCCC

About SI Shoulder Innovations Inc.

Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: